Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia

Journal of the National Cancer Institute
L F XiN B Kiviat

Abstract

Epidemiologic studies have demonstrated strong and consistent associations between the detection of human papillomavirus (HPV) type 16 DNA and the risk of cervical intraepithelial neoplasia (CIN) and cervical cancer. However, HPV16 is also the most common type of HPV in the normal population, and only a minority of women with HPV16 infection develop cervical cancer. Studies of genomic heterogeneity in HPV16 have demonstrated the presence of multiple variant forms in all human populations examined to date. It is conceivable that the natural variants of HPV16 in a given population may not have the same biologic behavior. This study was designed to determine the association between natural variants of HPV16 and the risk of biopsy-confirmed CIN 2 or 3, the most important precancerous lesions of the uterine cervix. Prospective studies were conducted among 1) women attending a university and 2) women presenting to a sexually transmitted disease clinic. Subjects were eligible for inclusion in this investigation if the initial cytologic findings did not reveal CIN 2-3 and HPV16 DNA was detected by means of a polymerase chain reaction (PCR)-based method in one or more cervical or vulvovaginal samples. Eligible subjects were followed eve...Continue Reading

References

Mar 18, 1992·Journal of the National Cancer Institute·M H Schiffman
May 1, 1992·Cancer·F ParazziniL Gallotta
Aug 19, 1991·International Journal of Cancer. Journal International Du Cancer·E A MorrisonR D Burk
Nov 1, 1989·Journal of Virology·E M de Villiers
Jan 1, 1988·Epidemiologic Reviews·L A KoutskyK K Holmes
Aug 1, 1985·Virology·K SeedorfW G Röwekamp
Sep 1, 1995·The Journal of Infectious Diseases·L F XiD A Galloway
Sep 20, 1995·Journal of the National Cancer Institute·G Y HoS Romney
Jun 16, 1993·Journal of the National Cancer Institute·M H SchiffmanS Wacholder

❮ Previous
Next ❯

Citations

Oct 1, 1998·International Journal of Cancer. Journal International Du Cancer·H J BontkesP L Stern
Mar 10, 2001·The Journal of Pathology·A Giannoudis, C S Herrington
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Paul K DrainLaura A Koutsky
Sep 19, 2002·International Journal of Cancer. Journal International Du Cancer·Anna H Beskow, Ulf B Gyllensten
Aug 10, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R TachezyE Hamsíková
Oct 19, 2006·Virus Genes·Tainá Raiol AlencarCláudia Renata Fernandes Martins
Feb 2, 2002·Current Oncology Reports·F Xavier Bosch, Silvia de Sanjosé
Nov 26, 2002·Virus Research·Allan Hildesheim, Sophia S Wang
Jul 19, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·K KurvinenS Syrjänen
Jun 26, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A Del Mistro, L Chieco Bianchi
Nov 25, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·A L Halpern
Oct 12, 2001·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·M SchmidtA Goździcka-Józefiak
Jan 30, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·María del Refugio González-LosaAlejandro García-Carrancá
Feb 28, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·T PangJ Ponten
Sep 6, 2001·Journal of the National Cancer Institute·J BerumenA Madrigal-de la Campa
Feb 22, 2001·Journal of the National Cancer Institute·A HildesheimR D Burk
Dec 19, 2002·Journal of the National Cancer Institute·May WongJack Gruber
Jun 23, 2000·Clinical Obstetrics and Gynecology·R H KaufmanV Vonka
Dec 24, 2003·The Cancer Journal·Eduardo L FrancoDebbie Saslow
Sep 22, 2005·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M E ScheurerK Adler-Storthz
May 10, 2006·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J J TuT C Wright
Sep 20, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P Mendoza-LorenzoM Salcedo
Nov 8, 2005·Journal of Clinical Microbiology·Sohrab BodaghiZhi-Ming Zheng
Apr 12, 2012·Journal of Virology·Iris CornetUNKNOWN IARC HPV Variant Study Group
Mar 29, 2002·Journal of Clinical Pathology·F X BoschK V Shah
Jan 25, 2013·Virology Journal·Chamsai PientongCheepsumon Suthipintawong
Mar 11, 2009·Frontiers in Bioscience (Landmark Edition)·Dukagjin M BlakajMichael Brenowitz
Mar 22, 2002·The Lancet Oncology·Alex Ferenczy, Eduardo Franco
Sep 29, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G VeressL Gergely

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.